Diabetes and obesity. Two diseases linked

Authors

  • Julio César Bragagnolo General Acute Hospital José María Ramos Mejía, Autonomous City of Buenos Aires, Argentina
  • Gustavo Daniel Frechtel Clinical Hospital (UBA), Autonomous City of Buenos Aires, Argentina
  • Carmen Sylvia Mazza Professor Hospital Dr. Juan Pedro Garrahan, Autonomous City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/diab.v56i1.522

Keywords:

editorial, diabetes, obesity

Abstract

Obesity is a chronic, progressive and recurrent disease. This is the simple, firm and evidence-based description that organizations and scientific societies of renown and global relevance use today. Obesity migrated in his consideration from a risk factor to a primary disease. It is not only a condition underlying chronic non-communicable diseases -such as cardiovascular disease (CVD), type 2 diabetes mellitus (DM2) or cancer, among others- but it is also a disease that affects the population in an epidemic form, universal and at any age.

Author Biographies

Julio César Bragagnolo, General Acute Hospital José María Ramos Mejía, Autonomous City of Buenos Aires, Argentina

Physician Specialist in Internal Medicine and Nutrition, Head of the Nutrition and Diabetes Unit; Associate and Associate Professor of the University of Buenos Aires; Professor of Diabetes Clinic and Pharmacology at the University of Salvador

Gustavo Daniel Frechtel, Clinical Hospital (UBA), Autonomous City of Buenos Aires, Argentina

Medical Specialist in Nutrition, Doctorate at the University of Buenos Aires; Full Professor of the Chair of Nutrition, Department of Medicine; Head of Nutrition Division

Carmen Sylvia Mazza, Professor Hospital Dr. Juan Pedro Garrahan, Autonomous City of Buenos Aires, Argentina

Pediatrician; Director of the Career of Medical Specialist in Pediatric Nutrition; Nutrition and Diabetes Service Consultant

References

I. Batsis JA, Sahakyan KR, Rodríguez-Escudero JP, Bar- tels SJ, López-Jiménez F. Normal weight obesity and functional outcomes in older adults. Eur J Intern Med 2014;25:517-522.

II. Bray GA, Kim KK, Wilding JPH; on behalf of World Obe- sity Federation. Obesity: a chronic relapsing progressive disease process. A position statemente of the World Obe- sity Federation. Obesity Reviews 2017;7:715-723.

III. Caballero B. Humans against Obesity: Who will win? Adv Nutr 2019 Jan1; 10 (suppl1):S4-S9.

IV. Carruba MD, Busetto L, Bryant S, et al. The European Association for the Study of Obesity (EASO) Endor- ses the Milan Charter on Urban Obesity. Obes Facts 2021;14:162-168.

V. Golay A,Ybarra J. Link between obesity and type 2 diabetes. Best Pract Res Clin Endocrinol Metab 2005;19(4):649- 663. doi: 10.1016/j.beem. 2005.07.01010.

VI. Haslam D. Obesity and diabetes: the links and common approaches. Prim Care Diabetes 2010;4(2):105-112. doi: 10.1016/j.pcd. 2010.04.00211.

VII. Haslam D. Weight management in obesity past and pre- sent. Int J Clin Pract 2016 Mar;70(3):206-17. doi: 10.1111/ ijcp.12771.

VIII. Hebebrand J, Holm JC, Woodward E, Baker, et al. A proposal of the European Association for the Study of Obe- sity to improve the IDC-11 diagnostic criteria for obesity base on the three dimensions etiology, degree of adiposity and health risk. Obes Facts 2017;10 (4):284-307.

IX. Hu FB. Globalization of diabetes. Role diet lifestyle ge- nes. 2011;34(6):1249-1257.29.

X. Jastreboff AM, Katz CM, Kohen S, Kelly AS. Heyms eld SB. Obesity as a disease.The Obesity 2018. Position Sta- tement. Obesity 2018;27:7-9.

XI. Klein S, Gastaldelli A, Yki-Järvinen H, Scherer PE. Why does obesity cause diabetes? Cell Metab 2022 Jan 4;34(1):11-20. doi: 10.1016/j.cmet.2021.12.012.

XII. KyleTK, Dhurandhar EJ, Allison DB. Regarding obesity as a disease. Endocrinol Metab Clin N Am 2016;45:511-520.

XIII. Sharma AM, Kushner RF. A proposed clinical staging system for obesity. International Journal of Obesity 2009;33(3):289-295.

Downloads

Published

2022-04-01

How to Cite

Bragagnolo, J. C., Frechtel, G. D., & Mazza, C. S. (2022). Diabetes and obesity. Two diseases linked. Journal of the Argentine Society of Diabetes, 56(1), 1–4. https://doi.org/10.47196/diab.v56i1.522

Issue

Vol. 56 No. 1 (2022): January/April 2022

Section

Editorial

License

Copyright (c) 2022 on behalf of the authors. Reproduction rights: Argentine Diabetes Society

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.

La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.

Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.

 

Most read articles by the same author(s)

1 2 > >>